NASDAQ
BTCY

Biotricity Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Biotricity Inc Stock Price

Vitals

Today's Low:
$2.0401
Today's High:
$2.2
Open Price:
$2.1594
52W Low:
$0.399
52W High:
$1.923
Prev. Close:
$2.11
Volume:
8916

Company Statistics

Market Cap.:
$35.71 million
Book Value:
-0.296
Revenue TTM:
$9.05 million
Operating Margin TTM:
-189.56%
Gross Profit TTM:
$4.57 million
Profit Margin:
-216.66%
Return on Assets TTM:
-77.4%
Return on Equity TTM:
-4100.79%

Company Profile

Biotricity Inc had its IPO on 2016-02-18 under the ticker symbol BTCY.

The company operates in the Healthcare sector and Medical Devices industry. Biotricity Inc has a staff strength of 44 employees.

Stock update

Shares of Biotricity Inc opened at $2.16 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.04 - $2.2, and closed at $2.08.

This is a -1.42% slip from the previous day's closing price.

A total volume of 8,916 shares were traded at the close of the day’s session.

In the last one week, shares of Biotricity Inc have increased by +0.97%.

Biotricity Inc's Key Ratios

Biotricity Inc has a market cap of $35.71 million, indicating a price to book ratio of 33.0205 and a price to sales ratio of 4.3477.

In the last 12-months Biotricity Inc’s revenue was $9.05 million with a gross profit of $4.57 million and an EBITDA of $-17140750. The EBITDA ratio measures Biotricity Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Biotricity Inc’s operating margin was -189.56% while its return on assets stood at -77.4% with a return of equity of -4100.79%.

In Q4, Biotricity Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 27.4%.

Biotricity Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.39 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Biotricity Inc’s profitability.

Biotricity Inc stock is trading at a EV to sales ratio of 5.902 and a EV to EBITDA ratio of -2.4763. Its price to sales ratio in the trailing 12-months stood at 4.3477.

Biotricity Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$6.65 million
Total Liabilities
$7.29 million
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Biotricity Inc ended 2024 with $6.65 million in total assets and $0 in total liabilities. Its intangible assets were valued at $6.65 million while shareholder equity stood at $-15481707.00.

Biotricity Inc ended 2024 with $0 in deferred long-term liabilities, $7.29 million in other current liabilities, 52242.00 in common stock, $-107713387.00 in retained earnings and $0 in goodwill. Its cash balance stood at $451421.00 and cash and short-term investments were $451421.00. The company’s total short-term debt was $3,448,519 while long-term debt stood at $12.64 million.

Biotricity Inc’s total current assets stands at $4.79 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $2.41 million compared to accounts payable of $2.38 million and inventory worth $1.93 million.

In 2024, Biotricity Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Biotricity Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$2.08
52-Week High
$1.923
52-Week Low
$0.399
Analyst Target Price
$2

Biotricity Inc stock is currently trading at $2.08 per share. It touched a 52-week high of $1.923 and a 52-week low of $1.923. Analysts tracking the stock have a 12-month average target price of $2.

Its 50-day moving average was $2.49 and 200-day moving average was $3.67 The short ratio stood at 1.39 indicating a short percent outstanding of 0%.

Around 1714.1% of the company’s stock are held by insiders while 532.2% are held by institutions.

Frequently Asked Questions About Biotricity Inc

The stock symbol (also called stock or share ticker) of Biotricity Inc is BTCY

The IPO of Biotricity Inc took place on 2016-02-18

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
Trimble Inc (TRMB)
$50.49
-0.3
-0.59%
$5858.25
-162.3
-2.7%
$10.57
0.01
+0.09%
$17.29
-0.15
-0.86%
Athenex Inc (ATNX)
$0.01
0
+103.33%
$23.17
0.49
+2.15%
$3.06
0.17
+5.88%
$509.65
-29
-5.38%
$8.39
0.02
+0.18%
$16.25
-0.07
-0.43%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Address

275 Shoreline Drive, Redwood City, CA, United States, 94065